Abstract
Cystic and polycystic diseases are genetic and congenital disorders in which cysts occur in the liver (simple cysts and autosomal dominant polycystic liver disease) or in combination with cysts in the kidneys (autosomal dominant polycystic kidney disease). Women have a higher prevalence with a female-to-male ratio of 1.5:1. Most of the patients are asymptomatic and can be managed conservatively. Severe symptoms can affect 20 % of patients who develop massive hepatomegaly with possible compression of surrounding organs. Rarely (<1 %), patients with polycystic disease suffer from acute complications caused by the torsion of giant and extrahepatic cysts, intraluminal cystic hemorrhage, and infections. The most common methods for the diagnosis of cystic and polycystic disease are cross-sectional imaging studies. Magnetic resonance imaging is more sensitive and specific, particularly for diagnosis of cysts communicating with the biliary tree. Different treatment options are available for these patients. Medical treatment has no role. Percutaneous sclerotherapy, transarterial embolization, surgical cyst fenestration , hepatic resection, and liver transplantation are indicated for specific groups of patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Bakoyiannis A, Delis S, Triantopoulou C, Dervenis C (2013) Rare cystic liver lesions: a diagnostic and managing challenge. World J Gastroenterol 19:7603–7619
Macedo FI (2013) Current management of noninfectious hepatic cystic lesions: a review of the literature. World J Hepatol 5:462–469
Del Poggio P, Buonocore M (2008) Cystic tumors of the liver: a practical approach. World J Gastroenterol 14:3616–3620
Farges O, Aussilhou B (2012) Simple cysts and polycystic liver disease: surgical and non-surgical management. In: Jarnagin WR, Blumgart LH (eds) Blumgart’s surgery of the liver, biliary tract and pancreas, 5th edn. Saunders, Philadelphia, pp 1066–1079
Shaked O, Siegelman ES, Olthoff EK, Reddy KR (2011) Biologic and clinical features of benign solid and cystic lesions of the liver. Clin Gastroenterol Hepatol 9:547–562
Carrim ZI, Murchison JT (2003) The prevalence of simple renal and hepatic cysts detected by spiral computed tomography. Clin Radiol 58:626–629
Lantinga MA, Gevers TJG, Drenth JPH (2013) Evaluation of hepatic cystic lesions. World J Gastroenterol 19:3543–3554
Choi BY, Nguyen MH (2005) The diagnosis and management of benign hepatic tumors. J Clin Gastroenterol 39:401–412
Sanfelippo PM, Beahrs OH, Weiland LH (1974) Cystic disease of the liver. Ann Surg 179:922–925
Jones WL, Mountain JC, Warren KW (1974) Symptomatic nonparasitic cysts of the liver. Br J Surg 61:118–123
Larssen TB, Rørvik J, Hoff SR, Horn A, Rosendahl K (2005) The occurrence of asymptomatic and symptomatic simple hepatic cysts. A prospective, hospital-based study. Clin Radiol 60:1026–1029
Taylor BR, Langer B (1997) Current surgical management of hepatic cyst disease. Adv Surg 31:127–148
Vachha B, Sun MR, Siewert B, Eisenberg RL (2011) Cystic lesions of the liver. AJR Am J Roentgenol 196:W355–W366
Yamada T, Furukawa K, Yokoi K, Mamada Y, Kanazawa Y, Tajiri T (2009) Liver cyst with biliary communication successfully treated with laparoscopic deroofing: a case report. J Nippon Med Sch 76:103–108
Treckmann JW, Paul A, Sgourakis G, Heuer M, Wandelt M, Sotiropoulos GC (2010) Surgical treatment of nonparasitic cysts of the liver: open versus laparoscopic treatment. Am J Surg 199:776–781
Yang CF, Liang HL, Pan HB, Lin YH, Mok KT, Lo GH, Lai KH (2006) Single-session prolonged alcohol-retention sclerotherapy for large hepatic cysts. AJR Am J Roentgenol 187:940–943
Loehe F, Globke B, Marnoto R, Bruns CJ, Graeb C, Winter H, Jauch KW, Angele MK (2010) Long-term results after surgical treatment of nonparasitic hepatic cysts. Am J Surg 200:23–31
Giuliani A, Migliaccio C, Ceriello A, Aragiusto G, La Manna G, Calise F (2014) Laparoscopic vs. open surgery for treating benign liver lesions: assessing quality of life in the first year after surgery. Updates Surg 66:127–133
Aldrighetti L, Cipriani F, Ratti F, Casciola L and Calise F on behalf of the Italian National Survey Group (2012) The Italian experience in minimally invasive surgery of the liver: a national survey. In: Calise F, Casciola L (eds) Minimally, surgery of the liver, Springer, Milan, pp 295–312
Tahvanainen P, Tahvanainen E, Reijonen H, Halme L, Kaariainen H, Hockrstedt K (2003) Polycystic liver disease is genetically heterogeneous: clinical and linkage studies in eight Finnish families. J Hepatol 38:39–43
Drenth JP, Martina JA, Te Morsche RH, Jansen JB, Bonifacino JS (2004) Molecular characterization of hepatocystin, the protein that is defective in autosomal dominant polycystic liver disease. Gastroenterol 126:1819–1827
Drenth JP, te Morsche RH, Smink R, Bonifacino JS, Jansen JB (2003) Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease. Nat Genet 33:345–347
Li A, Davila S, Furu L, Qian Q, Tian X, Kamath PS, King BF, Torres VE, Somlo S (2003) Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease. Am J Hum Genet 72:691–703
Waanders E, Venselaar H, te Morsche RH, de Koning DB, Kamath PS, Torres VE, Somlo S, Drenth JP (2010) Secondary and tertiary structure modeling reveals effects of novel mutations in polycystic liver disease genes PRKCSH and SEC63. Clin Genet 78:47–56
Woodford LM, Grantham JJ, Bennett WM, Meyers CM, Walker DL, Bae K, Zhang QJ, Thompson PA, Miller JP, Harris PC (2007) Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 18:2143–2160
Janssen MJ, Waanders E, Woudenberg J, Lefeber DJ, Drenth JP (2010) Congenital disorders of glycosylation in hepatology: the example of polycystic liver disease. J Hepatol 52:432–440
Everson GT, Taylor MR, Doctor RB (2004) Polycystic disease of the liver. Hepatology 40:774–782
Torres VE, Harris PC (2009) Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int 76:149–168
Murray SL, Grubman SA, Perrone RD, Perrone RD, Rojkind M, Moy E, Lee DW, Jefferson DM (1996) Matrix metalloproteinase activity in human intrahepatic biliary epithelial cell lines from patients with autosomal dominant polycystic kidney disease. Connect Tissue Res 33:249–256
Alvaro D, Gigliozzi A, Attili AF (2000) Regulation and deregulation of cholangiocyte proliferation. J Hepatol 33:333–340
Everson GT (1993) Hepatic cysts in autosomal dominant polycystic kidney disease. Am J Kidney Dis 22:520–525
Temmerman F, Missiaen L, Bammens B, Laleman W, Cassiman D, Verslype C, van Pelt J, Nevens F (2011) Systematic review: the pathophysiology and management of polycystic liver disease. Aliment Pharmacol Ther 34:702–713
Van Keimpema L, De Koning DB, Van Hoek B, Van Den Berg AP, Van Oijen MG, De Man RA, Nevens F, Drenth JP (2011) Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases. Liver Int 31:92–98
Qian Q, Li A, King BF, Kamath PS, Lager DJ, Huston J, Shub C, Davila S, Somlo S, Torres VE (2003) Clinical profile of autosomal dominant polycystic liver disease. Hepatology 37:164–171
Gigot JF, Jadoul P, Que F, Van Beers BE, Etienne J, Horsmans Y, Collard A, Geubel A, Pringot J, Kestens PJ (1997) Adult polycystic liver disease: is fenestration the most adequate operation for long-term management? Ann Surg 225:286–294
Johnson DK, Panchili S, Kolasseri S, Mavali RT (2014) Polycystic liver disease presenting as pruritus. Ann Gastroenterol 27:76–78
Pirson Y, Chauveau D, Torres V (2002) Management of cerebral aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 13:269–276
Schnelldorfer T, Torres VE, Zakaria S, Rosen CB, Nagorney DM (2009) Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation. Ann Surg 250:112–118
Hogan MC, Masyuk TV, Page LJ, Kubly VJ, Bergstralh EJ, Li X, Kim B, King BF, Glockner J, Holmes DR, Rossetti S, Harris PC, LaRusso NF, Torres VE (2010) Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease. J Am Soc Nephrol 21:1052–1061
Hogan MC, Masyuk TV, Page L, Holmes DR, Li X, Bergstralh EJ, Irazabal MV, Kim B, King BF, Glockner JF, Larusso NF, Torres VE (2012) Somatostatin analog therapy for severe polycystic liver disease: results after 2 years. Nephrol Dial Transplant 27:3532–3539
Caroli A, Perico N, Perna A, Antiga L, Brambilla P, Pisani A, Visciano B, Imbriaco M, Messa P, Cerutti R, Dugo M, Cancian L, Buongiorno E, De Pascalis A, Gaspari F, Carrara F, Rubis N, Prandini S, Remuzzi A, Remuzzi G, Ruggenenti P, ALADIN Study Group (2013) Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial. Lancet 382:1485–1495
Takei R, Ubara Y, Hoshino J, Higa Y, Suwabe T, Sogawa Y, Nomura K, Nakanishi S, Sawa N, Katori H, Takemoto F, Hara S, Takaichi K (2007) Percutaneous transcatheter hepaticartery embolization for liver cysts in autosomal dominant polycystic kidney disease. Am J Kidney Dis 49:744–752
Robinson TN, Stiegmann GV, Everson GT (2005) Laparoscopic palliation of polycystic liver disease. Surg Endosc 19:130–132
Stickel F, Inderbitzin D, Candinas D (2008) Role of nutrition in liver transplantation for end-stage chronic liver disease. Nutr Rev 66:47–54
van Keimpema L, Nevens F, Adam R, Porte RJ, Fikatas P, Becker T, Kirkegaard P, Metselaar HJ, Drent JPH, for the European Liver and Intestine Transplant Association (ELITA) (2011) Excellent survival after liver transplantation for isolated polycystic liver disease: an European Liver Transplant Registry study. Transplant Int 24:1239–1245
Freeman RB Jr, Gish RG, Harper A, Davis GL, Vierling J, Lieblein L, Klintmalm G, Blazek J, Hunter R, Punch J (2006) Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula. Liver Transpl 12:S128–S136
Arrazola L, Moonka D, Gish RG, Everson GT (2006) Model for end-stage liver disease (MELD) exception for polycystic liver disease. Liver Transpl 12:S110–S111
Pirenne J, Aerts R, Yoong K, Gunson B, Koshiba T, Fourneau I, Mayer D, Buckels J, Mirza D, Roskams T, Elias E, Nevens F, Fevery J, McMaster P (2001) Liver transplantation for polycystic liver disease. Liver Transpl 7:238–245
Kirchner GI, Rifai K, Cantz T, Nashan B, Terkamp C, Becker T, Strassburg C, Barg-Hock H, Wagner S, Lück R, Klempnauer J, Manns MP (2006) Outcome and quality of life in patients with polycystic liver disease after liver or combined liver-kidney transplantation. Liver Transpl 12:1268
Rasmussen A, Davies HF, Jamieson NV, Evans DB, Calne RY (1995) Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival. Transplantation 59:919–921
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing AG Switzerland
About this chapter
Cite this chapter
Giuliani, A., Aloia, S., Crolla, E., Sodano, L., Rocca, A., Calise, F. (2015). Cysts and Polycystic Liver Disease. In: Aldrighetti, L., Cetta, F., Ferla, G. (eds) Benign Tumors of the Liver. Springer, Cham. https://doi.org/10.1007/978-3-319-12985-3_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-12985-3_8
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-12984-6
Online ISBN: 978-3-319-12985-3
eBook Packages: MedicineMedicine (R0)